Right-sided infective endocarditis: Surgical management

European Journal of Cardio-thoracic Surgery

Volumn 42, Issue 3, 2012, Pages 470-479

  Akinosoglou, Karolina ^a,b   Apostolakis, Efstratios ^c   Koutsogiannis, Nikolaos ^b   Leivaditis, Vassilios ^b   Gogos, Charalambos A ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^c UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Implantable cardioverter defibrillator endocarditis; Pacemaker endocarditis; Right sided infective endocarditis; Tricuspid valve repair; Tricuspid valve replacement; Tricuspid valvulectomy

Indexed keywords

ANTIBIOTIC AGENT; DAPTOMYCIN; GENTAMICIN; VANCOMYCIN;

ANNULOPLASTY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL HEART; BACTERIAL ENDOCARDITIS; CLINICAL FEATURE; DISEASE PREDISPOSITION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTRAVENOUS DRUG ABUSE; PACEMAKER; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RIGHT SIDED INFECTIVE ENDOCARDITIS; SEPSIS; STAPHYLOCOCCUS; STREPTOCOCCUS; SURGICAL TECHNIQUE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ADULT; COMPARATIVE STUDY; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HEART ATRIUM; HEART SURGERY; HEART VALVE REPLACEMENT; HEART VENTRICLE; MALE; MEDICAL EDUCATION; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PULMONARY VALVE; REVIEW; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE; SURVIVAL RATE; TRICUSPID VALVE; VALVULAR HEART DISEASE;

ADULT; CARDIAC SURGICAL PROCEDURES; ECHOCARDIOGRAPHY, DOPPLER; EDUCATION, MEDICAL, CONTINUING; ENDOCARDITIS, BACTERIAL; FEMALE; HEART ATRIA; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY VALVE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE, INTRAVENOUS; SURVIVAL RATE; TREATMENT OUTCOME; TRICUSPID VALVE; YOUNG ADULT;

EID: 84872685763     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs084     Document Type: Article

References (84)

1. Chan P, Ogilby JD, Segal B. Tricuspid valve endocarditis. Am Heart J 1989;117:1140-6.
2. Frontera JA, Gradon JD. Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis 2000; 30:374-9.
3. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007;49: 1851-9.
4. del Rio A, Anguera I, Miro JM, Mont L, Fowler VG Jr, Azqueta M et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest 2003;124:1451-9.
5. Alexiou C, Langley SM, Monro JL. Surgery for infective valve endocarditis in children. Eur J Cardiothorac Surg 1999;16:653-9.
6. Morokuma H, Minato N, Kamohara K, Minematsu N. Three surgical cases of isolated tricuspid valve infective endocarditis. Ann Thorac Cardiovasc Surg 2010;16:134-8.
7. Musci M, Siniawski H, Pasic M, Grauhan O, Weng Y, Meyer R et al. Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience. Eur J Cardiothorac Surg 2007;32:118-25.
8. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, Wilson WR et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc 2008;83: 46-53.
9. Chrissoheris MP, Libertin C, Ali RG, Ghantous A, Bekui A, Donohue T. Endocarditis complicating central venous catheter bloodstream infections: a unique form of health care associated endocarditis. Clin Cardiol 2009;32:E48-54.
10. Hecht SR, Berger M. Right-sided endocarditis in intravenous drug users: prognostic features in 102 episodes. Ann Intern Med 1992;117:560-6.
11. Moss R, Munt B. Injection drug use and right sided endocarditis. Heart 2003;89:577-81.
12. Grover A, Anand IS, Varma J, Choudhury R, Khattri HN, Sapru RP et al. Profile of right-sided endocarditis: an Indian experience. Int J Cardiol 1991;33:83-8.
13. Cabell CH, Heidenreich PA, Chu VH, Moore CM, Stryjewski ME, Corey GR et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J 2004;147:582-6.
14. Revilla A, López J, Villacorta E, Gómez I, Sevilla T, del Pozo MA et al. Isolated right-sided valvular endocarditis in non-intravenous drug users. Rev Esp Cardiol 2008;61:1253-9.
15. Ruttmann E, Hangler HB, Kilo J, Hofer D, Muller LC, Hintringer F et al. Transvenous pacemaker lead removal is safe and effective even in large vegetations: an analysis of 53 cases of pacemaker lead endocarditis. Pacing Clin Electrophysiol 2006;29:231-6.
16. Rankin JS, Milford-Beland S, O'Brien SM, Edwards FH, Peterson ED, Glower DD et al. The risk of valve surgery for endocarditis in patients with dialysis-dependent renal failure. J Heart Valve Dis 2007;16:617-22; discussion 622.
17. Nori US, Manoharan A, Thornby JI, Yee J, Parasuraman R, Ramanathan V. Mortality risk factors in chronic haemodialysis patients with infective endocarditis. Nephrol Dial Transplant 2006;21:2184-90.
18. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I et al. Guidelines on the Prevention, Diagnosis, and Treatment of Infective Endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009;30:2369-413.
19. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis 2001;32:50-62.
20. Pierrotti LC, Baddour LM. Fungal endocarditis, 1995-2000. Chest 2002; 122:302-10.
21. Martin-Davila P, Navas E, Fortun J, Moya JL, Cobo J, Pintado V et al. Analysis of mortality and risk factors associated with native valve endocarditis in drug users: the importance of vegetation size. Am Heart J 2005;150:1099-106.
22. Nucifora G, Badano L, Hysko F, Allocca G, Gianfagna P, Fioretti P. Pulmonary embolism and fever: when should right-sided infective endocarditis be considered? Circulation 2007;115:e173-6.
23. Pesanti E, Smith IM. Infective endocarditis with negative blood cultures: an analysis of 52 cases. Am J Med 1979;66:43-50.
24. San Roman JA, Vilacosta I. Role of transesophageal echocardiography in right-sided endocarditis. Echocardiography 1995;12:669-72.
25. Margey R, McCann H, Blake G, Keelan E, Galvin J, Lynch M et al. Contemporary management of and outcomes from cardiac device related infections. Europace 2010;12:64-70.
26. Bayer AS, Blomquist IK, Bello E, Chiu CY, Ward JI, Ginzton LE. Tricuspid valve endocarditis due to Staphylococcus aureus: correlation of twodimensional echocardiography with clinical outcome. Chest 1988;93: 247-53.
27. Gottardi R, Bialy J, Devyatko E, Tschernich H, Czerny M, Wolner E et al. Midterm follow-up of tricuspid valve reconstruction due to active infective endocarditis. Ann Thorac Surg 2007;84:1943-8.
28. Head SJ, Mokhles MM, Osnabrugge RL, Bogers AJ, Kappetein AP. Surgery in current therapy for infective endocarditis. Vasc Health Risk Manag 2011;7:255-63.
29. Uslan DZ, Baddour LM. Cardiac device infections: getting to the heart of the matter. Curr Opin Infect Dis 2006;19:345-8.
30. Cacoub P, Leprince P, Nataf P, Hausfater P, Dorent R, Wechsler B et al. Pacemaker infective endocarditis. Am J Cardiol 1998;82:480-4.
31. Lowes JA, Hamer J, Williams G, Houang E, Tabaqchali S, Shaw EJ et al. 10 Years of infective endocarditis at St. Bartholomew's Hospital: analysis of clinical features and treatment in relation to prognosis and mortality. Lancet 1980;1:133-6.
32. Moon MR, Stinson EB, Miller DC. Surgical treatment of endocarditis. Prog Cardiovasc Dis 1997;40:239-64.
33. Remadi JP, Habib G, Nadji G, Brahim A, Thuny F, Casalta JP et al. Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis. Ann Thorac Surg 2007;83:1295-302.
34. Rubinstein E, Lang R. Fungal endocarditis. Eur Heart J 1995;16(Suppl B): 84-9.
35. Morpeth S, Murdoch D, Cabell CH, Karchmer AW, Pappas P, Levine D et al. Non-HACEK Gram-negative bacillus endocarditis. Ann Intern Med 2007;147:829-35.
36. Jacobs F, Abramowicz D, Vereerstraeten P, Le Clerc JL, Zech F, Thys JP. Brucella endocarditis: the role of combined medical and surgical treatment. Rev Infect Dis 1990;12:740-4.
37. Tasdemir K, Kaya MG, Mavili E, Gunebakmaz O, Ozbek A, Sarli B et al. Surgical approach to the management of brucella endocarditis. Eur J Cardiothorac Surg 2010;37:1021-4.
38. Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A et al. Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary: the Task Force on Infective Endocarditis of the European Society of Cardiology. Eur Heart J 2004;25: 267-76.
39. Frater RW. Surgical management of endocarditis in drug addicts and long-term results. J Card Surg 1990;5:63-7.
40. DiNubile M. Surgery for addiction-related tricuspid valve endocarditis: caveat emptor. Am J Med 1987;82:811-3.
41. Yee ES, Khonsari S. Right-sided infective endocarditis: valvuloplasty, valvectomy or replacement. J Cardiovasc Surg (Torino) 1989;30: 744-8.
42. Allen MD, Slachman F, Eddy AC, Cohen D, Otto CM, Pearlman AS. Tricuspid valve repair for tricuspid valve endocarditis: tricuspid valve 'recycling'. Ann Thorac Surg 1991;51:593-8.
43. Lange R, De Simone R, Bauernschmitt R, Tanzeem A, Schmidt C, Hagl S. Tricuspid valve reconstruction, a treatment option in acute endocarditis. Eur J Cardiothorac Surg 1996;10:320-6.
44. David TE. Replacement of chordae tendineae with expanded polytetrafluoroethylene sutures. J Card Surg 1989;4:286-90.
45. Carozza A, Renzulli A, De Feo M, Ismeno G, Della Corte A, Dialetto G et al. Tricuspid repair for infective endocarditis: clinical and echocardiographic results. Tex Heart Inst J 2001;28:96-101.
46. Filsoufi F, Salzberg SP, Abascal V, Adams DH. Surgical management of functional tricuspid regurgitation with a new remodeling annuloplasty ring. Mount Sinai J Med 2006;73:874-79.
47. Kay J, Maselli-Campagna G, Tsuji K. Surgical treatment of tricuspid insufficiency. Ann Surg 1965;162:53-8.
48. De Vega NG, de Rabago G, Castillon L. A new tricuspid repair: shortterm clinical results in 23 cases. J Cardiovasc Surg (Torino) 1973;14: 384-6.
49. Couetil JP, Argyriadis PG, Shafy A, Cohen A, Berrebi AJ, Loulmet DF et al. Partial replacement of the tricuspid valve by mitral homografts in acute endocarditis. Ann Thorac Surg 2002;73:1808-12.
50. Mangoni AA, DiSalvo TG, Vlahakes GJ, Polanczyk CA, Fifer MA. Outcome following isolated tricuspid valve replacement. Eur J Cardiothorac Surg 2001;19:68-73.
51. Tokunaga S, Masuda M, Shiose A, Tomita Y, Morita S, Tominaga R. Long-term results of isolated tricuspid valve replacement. Asian Cardiovasc Thorac Ann 2008;16:25-8.
52. Arbulu A, Holmes RJ, Asfaw I. Surgical treatment of intractable rightsided infective endocarditis in drug addicts: 25 years' experience. J Heart Valve Dis 1993;2:129-37; discussion 138-9.
53. Arbulu A, Holmes RJ, Asfaw I. Tricuspid valvulectomy without replacement: twenty years' experience. J Thorac Cardiovasc Surg 1991;102: 917-22.
54. Stern HJ, Sisto DA, Strom JA, Soeiro R, Jones SR, Frater RW. Immediate tricuspid valve replacement for endocarditis: indications and results. J Thorac Cardiovasc Surg 1986;91:163-7.
55. Munro AI, Jamieson WR, Tyers GF, Germann E. Tricuspid valve replacement: porcine bioprostheses and mechanical prostheses. Ann Thorac Surg 1995;60(Suppl 2):S470-4.
56. Arbulu A. Trivalvular/bivalvular heart: a philosophical, scientific and therapeutic concept. J Heart Valve Dis 2000;9:353-7; discussion 357-8.
57. Miro JM, del Rio A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin 2003;21:167-84, v-vi.
58. Shemin R. Tricuspid valve disease. In: Cohn L (ed). Cardiac Surgery in the Adult, 3rd edn. New York, Chicago, San Francisco: McGraw-Hill, 2008, 1118-22.
59. Aoki K, Watanabe M, Ohzeki H. Successful surgical treatment of tricuspid valve endocarditis associated with vertebral osteomyelitis. Ann Thorac Cardiovasc Surg 2010;16:207-9.
60. Matsuyama K, Matsumoto M, Sugita T, Nishizawa J, Tokuda Y, Matsuo T et al. De Vega annuloplasty and Carpentier-Edwards ring annuloplasty for secondary tricuspid regurgitation. J Heart Valve Dis 2001;10:520-4.
61. Carpentier A. Cardiac valve surgery-the 'French correction'. J Thorac Cardiovasc Surg 1983;86:323-37.
62. Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg 2005;79:127-32.
63. McCarthy PM, Bhudia SK, Rajeswaran J, Hoercher KJ, Lytle BW, Cosgrove DM et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg 2004;127:674-85.
64. Hanai M, Hashimoto K, Mashiko K, Sasaki T, Sakamoto Y, Shiratori K et al. Active infective endocarditis: management and risk analysis of hospital death from 24 years' experience. Circ J 2008;72:2062-8.
65. Van Nooten GJ, Caes F, Taeymans Y, Van Belleghem Y, Francois K, De Bacquer D et al. Tricuspid valve replacement: postoperative and longterm results. J Thorac Cardiovasc Surg 1995;110:672-9.
66. Wilcox BR, Murray GF, Starek PJ. The long-term outlook for valve replacement in active endocarditis. J Thorac Cardiovasc Surg 1977;74: 860-3.
67. Cooper JP, Jayawickreme SR, Swanton RH. Permanent pacing in patients with tricuspid valve replacements. Br Heart J 1995;73:169-72.
68. Miyagishima RT, Brumwell ML, Eric Jamieson WR, Munt BI. Tricuspid valve replacement using a cryopreserved mitral homograft: surgical technique and initial results. J Heart Valve Dis 2000;9:805-8; discussion 808-9.
69. Cardarelli MG, Gammie JS, Brown JM, Poston RS, Pierson RN III, Griffith BP. A novel approach to tricuspid valve replacement: the upside down stentless aortic bioprosthesis. Ann Thorac Surg 2005;80:507-10.
70. Romano G, Carozza A, Della Corte A, De Santo LS, Amarelli C, Torella M et al. Native versus primary prosthetic valve endocarditis: comparison of clinical features and long-term outcome in 353 patients. J Heart Valve Dis 2004;13:200-8; discussion 208-9.
71. Kaiser S, Melby SJ, Zierer A, Schuessler RB, Moon MR, Moazami N et al. Long-term outcomes in valve replacement surgery for infective endocarditis. Ann Thorac Surg. 2007;83:30-5.
72. Al-Ebrahim KE. Tricuspid valve replacement is an unfavourable operation. Eur J Cardiothorac Surg 2010;38:115.
73. Feringa HH, Shaw LJ, Poldermans D, Hoeks S, van der Wall EE, Dion RA et al. Mitral valve repair and replacement in endocarditis: a systematic review of literature. Ann Thorac Surg 2007;83:564-70.
74. Jung SH, Je HG, Choo SJ, Song H, Chung CH, Lee JW. Surgical results of active infective native mitral valve endocarditis: repair versus replacement. Eur J Cardiothorac Surg 2011;40:834-9.
75. Guenther T, Noebauer C, Mazzitelli D, Busch R, Tassani-Prell P, Lange R. Tricuspid valve surgery: a thirty-year assessment of early and late outcome. Eur J Cardiothorac Surg 2008;34:402-9; discussion 409.
76. Singh SK, Tang GH, Maganti MD, Armstrong S, Williams WG, David TE et al. Midterm outcomes of tricuspid valve repair versus replacement for organic tricuspid disease. Ann Thorac Surg 2006;82:1735-41; discussion 1741.
77. Moraca RJ, Moon MR, Lawton JS, Guthrie TJ, Aubuchon KA, Moazami N et al. Outcomes of tricuspid valve repair and replacement: a propensity analysis. Ann Thorac Surg 2009;87:83-8; discussion 88-9.
78. Ohata T, Kigawa I, Tohda E, Wanibuchi Y. Comparison of durability of bioprostheses in tricuspid and mitral positions. Ann Thorac Surg 2001;71 (Suppl 5):S240-3.
79. Nakano K, Ishibashi-Ueda H, Kobayashi J, Sasako Y, Yagihara T. Tricuspid valve replacement with bioprostheses: long-term results and causes of valve dysfunction. Ann Thorac Surg 2001;71:105-9.
80. Moon MR, Miller DC, Moore KA, Oyer PE, Mitchell RS, Robbins RC et al. Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg 2001;71: 1164-71.
81. Ratnatunga CP, Edwards MB, Dore CJ, Taylor KM. Tricuspid valve replacement: UK Heart Valve Registry mid-term results comparing mechanical and biological prostheses. Ann Thorac Surg 1998;66:1940-7.
82. Kaplan M, Kut MS, Demirtas MM, Cimen S, Ozler A. Prosthetic replacement of tricuspid valve: bioprosthetic or mechanical. Ann Thorac Surg 2002;73:467-73.
83. Rizzoli G, Vendramin I, Nesseris G, Bottio T, Guglielmi C, Schiavon L. Biological or mechanical prostheses in tricuspid position A meta-analysis of intra-institutional results. Ann Thorac Surg 2004;77:1607-14.
84. Morris A, Drinkovic D, Pottumarthy S, MacCulloch D, Kerr AR, West T. Bacteriological outcome after valve surgery for active infective endocarditis: implications for duration of treatment after surgery. Clin Infect Dis 2005;41:187-94.